http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6087495-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-10
filingDate 1997-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8155932acc842d97cbc8c4f0da049bf4
publicationDate 2000-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6087495-A
titleOfInvention Process for the preparation of galanthamine
abstract The subject invention concerns a process for the preparation of enantiomerically-enriched galanthamine from racemic galanthamine, and a process for increasing the enantiomeric excess of enantiomerically-enriched galanthamine, by direct crystallization of galanthamine salts.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015108634-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005142193-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005191349-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019050582-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006013546-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006013546-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3094681-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022015627-A2
priorityDate 1996-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129011494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12049127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127454203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127454204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128889757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226440121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129011495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226466318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226538967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53442768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID558230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16757785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226452397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID625124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136219307
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54223935

Total number of triples: 40.